Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Lucid Diagnostics Inc. (LUCD)

1.1900
-0.0400
(-3.25%)
At close: 4:00:01 PM EDT
1.1900
0.00
(0.00%)
After hours: 4:05:10 PM EDT
Advanced Chart
Loading Chart for LUCD
  • Previous Close 1.2300
  • Open 1.2300
  • Bid 1.1500 x 500
  • Ask 1.2400 x 500
  • Day's Range 1.1900 - 1.2450
  • 52 Week Range 0.6810 - 1.8000
  • Volume 1,734,566
  • Avg. Volume 1,106,800
  • Market Cap (intraday) 125.406M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0500
  • Earnings Date May 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.75

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

www.luciddx.com

72

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about Lucid Diagnostics Inc.

Recent News: LUCD

View More
View More

Performance Overview: LUCD

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LUCD
45.30%
S&P 500 (^GSPC)
4.26%

1-Year Return

LUCD
15.53%
S&P 500 (^GSPC)
8.55%

3-Year Return

LUCD
43.06%
S&P 500 (^GSPC)
36.57%

5-Year Return

LUCD
90.67%
S&P 500 (^GSPC)
95.45%

Compare To: LUCD

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

LUCD
Lucid Diagnostics Inc.
1.1900
-3.25%
Mkt Cap 125.406M
Industry Medical Devices
PAVM
PAVmed Inc.
0.7351
-4.47%
Mkt Cap 12.565M
Industry Medical Devices
RCEL
AVITA Medical, Inc.
9.47
+2.77%
Mkt Cap 250.204M
Industry Medical Devices
DCTH
Delcath Systems, Inc.
11.61
-0.94%
Mkt Cap 388.152M
Industry Medical Devices
RPID
Rapid Micro Biosystems, Inc.
2.3200
+1.31%
Mkt Cap 101.682M
Industry Medical Devices
NUWE
Nuwellis, Inc.
0.9401
-3.67%
Mkt Cap 4.112M
Industry Medical Devices
PROF
Profound Medical Corp.
4.7400
-4.44%
Mkt Cap 142.452M
Industry Medical Devices
PAVMZ
PAVmed Inc.
0.0009
-40.00%
Mkt Cap -
Industry Medical Devices
XTNT
Xtant Medical Holdings, Inc.
0.5183
+1.91%
Mkt Cap 72.204M
Industry Medical Devices
INBS
Intelligent Bio Solutions Inc.
1.1450
-4.58%
Mkt Cap 7.768M
Industry Medical Devices
LUNG
Pulmonx Corporation
3.6800
+6.98%
Mkt Cap 148.148M
Industry Medical Devices

Statistics: LUCD

View More

Valuation Measures

Annual
As of 5/6/2025

  • Market Cap

    129.31M

  • Enterprise Value

    182.62M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.30

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    42.02

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -99.28%

  • Return on Equity (ttm)

    -2,956.43%

  • Revenue (ttm)

    4.35M

  • Net Income Avi to Common (ttm)

    -53.02M

  • Diluted EPS (ttm)

    -1.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.7M

  • Total Debt/Equity (mrq)

    206.15%

  • Levered Free Cash Flow (ttm)

    -34.57M

View More

Research Analysis: LUCD

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.2M
Earnings -10.88M

Q1'24

Q2'24

Q3'24

Q4'24

-10M
-8M
-6M
-4M
-2M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

2.00
3.75 Average
1.1900 Current
7.50 High
 
View More

People Also Watch

PAVM PAVmed Inc.
0.7351
-4.47%
 
RPID Rapid Micro Biosystems, Inc.
2.3200
+1.31%
 
HCWB HCW Biologics Inc.
7.01
+2.34%
 
CGTX Cognition Therapeutics, Inc.
0.3547
-15.04%
 
IOBT IO Biotech, Inc.
0.9850
-7.94%
 
INAB IN8bio, Inc.
0.1645
+0.43%
 
UNCY Unicycive Therapeutics, Inc.
0.6371
+5.22%
 
BDSX Biodesix, Inc.
0.4237
-5.45%
 
UTRS Minerva Surgical, Inc.
0.0001
0.00%
 
BJDX Bluejay Diagnostics, Inc.
1.7217
-2.18%
 
DRMA Dermata Therapeutics, Inc.
0.8778
+0.02%
 
SONX Sonendo, Inc.
1.4000
+21.74%
 
RNXT RenovoRx, Inc.
1.0550
+2.43%
 
CNTX Context Therapeutics Inc.
0.7730
-4.28%
 
MDXH MDxHealth SA
1.7100
+1.18%
 
SABS SAB Biotherapeutics, Inc.
1.6901
+4.33%